- Home
- ASND vs CAVA Comparison
ASND vs CAVA Comparison
Compare ASND & CAVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASND
- CAVA
- Stock Information
- Founded
- ASND 2006
- CAVA 2006
- Country
- ASND Denmark
- CAVA United States
- Employees
- ASND N/A
- CAVA N/A
- Industry
- ASND Biotechnology: Pharmaceutical Preparations
- CAVA Restaurants
- Sector
- ASND Health Care
- CAVA Consumer Discretionary
- Exchange
- ASND Nasdaq
- CAVA Nasdaq
- Market Cap
- ASND 10.6B
- CAVA 10.0B
- IPO Year
- ASND 2015
- CAVA 2023
- Fundamental
- Price
- ASND $198.32
- CAVA $69.90
- Analyst Decision
- ASND Strong Buy
- CAVA Buy
- Analyst Count
- ASND 16
- CAVA 16
- Target Price
- ASND $239.50
- CAVA $103.69
- AVG Volume (30 Days)
- ASND 549.0K
- CAVA 6.1M
- Earning Date
- ASND 08-07-2025
- CAVA 08-12-2025
- Dividend Yield
- ASND N/A
- CAVA N/A
- EPS Growth
- ASND N/A
- CAVA 213.93
- EPS
- ASND N/A
- CAVA 1.18
- Revenue
- ASND $576,332,355.00
- CAVA $1,083,653,000.00
- Revenue This Year
- ASND $79.35
- CAVA $26.07
- Revenue Next Year
- ASND $76.18
- CAVA $21.48
- P/E Ratio
- ASND N/A
- CAVA $59.27
- Revenue Growth
- ASND 54.50
- CAVA 28.21
- 52 Week Low
- ASND $111.09
- CAVA $65.70
- 52 Week High
- ASND $199.99
- CAVA $172.43
- Technical
- Relative Strength Index (RSI)
- ASND 69.11
- CAVA 32.49
- Support Level
- ASND $187.24
- CAVA $65.70
- Resistance Level
- ASND $197.67
- CAVA $90.35
- Average True Range (ATR)
- ASND 8.86
- CAVA 3.42
- MACD
- ASND 1.92
- CAVA -2.28
- Stochastic Oscillator
- ASND 95.73
- CAVA 16.44
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.
About CAVA CAVA Group Inc.
Cava Group Inc owns and operates a chain of restaurants. It is the category-defining Mediterranean fast-casual restaurant brand, bringing together healthful food and bold, satisfying flavors at scale. The company's dips, spreads, and dressings are centrally produced and sold in grocery stores. The company's operations are conducted as two reportable segments: CAVA and Zoes Kitchen. The company generates all of its revenue from the CAVA segment.